Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Public discussions about personal health are currently experiencing a very positive shift. Today, numerous prominent figures openly share their successful medical journeys. These honest accounts actively reduce the longstanding social stigma surrounding obesity. People now view metabolic conditions through a…
For a long time, trying to manage weight felt like an uphill battle. Doctors and patients simply did not have many tools that worked well over the long term. But things are finally looking up for metabolic health. Late in…
A new forecast from pharmaceutical intelligence firm Evaluate suggests Eli Lilly’s tirzepatide franchise is on track to make commercial history. The company’s World Preview report projects that Mounjaro and Zepbound could together generate more than $70 billion in annual sales…
Zepbound has truly transformed the landscape of medical weight management. As one of the most effective treatments available today, it offers remarkable results for people struggling with obesity and metabolic health. Patients are seeing life-changing benefits, from significant weight reduction…
CVS Caremark, the largest pharmacy benefit manager in the United States, is reversing a controversial decision. The company cut off coverage for one of the country’s most prescribed obesity medications last year. Now, it is bringing that coverage back. Starting…
Eli Lilly took a notable step toward closing the obesity treatment access gap in March 2026. The company launched a direct-to-employer platform that lets businesses offer its weight loss drug Zepbound to workers outside the traditional insurance system. The program…